Abstract Coronavirus disease 2019 (COVID-19) caused by the novel coronavirus has
become a Public Health Emergency of International Concern. Among the various treatment …

Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory coronavirus 2
(SARS-CoV-2), has rapidly spread since its first declaration by the World Health …

Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of
coronavirus disease (COVID-19), spreading from Wuhan to worldwide has been emerged …

• There is some evidence for favourable outcomes in patients who have received COVID-19
convalescent plasma, but it is not definitive. WHO recognizes COVID-19 convalescent …

Every severe viral infection since the Spanish Flu has stimulated interest in passive
immunotherapy, in the absence of antiviral treatment and a vaccine program [1]. The …

Background Convalescent plasma has been used for a long time for the treatment of various
infectious diseases. The principle is to collect antibody-containing plasma from recovered …

December 2019 marked the emergence of a new deadly strain of the coronavirus family
which unleashed an unprecedented pandemic named the coronavirus disease 2019 …

The objective of this study was to highlight the global scientific effort to fight the SARS-CoV-
2, addressing the preliminary results of passive immunization through convalescent plasma …

Background. COVID-19, caused by the SARS-CoV-2 virus, is a pandemic disease with high
morbidity and mortality. Currently, available therapeutic options for COVID-19 are limited …

In these times of COVID-19 pandemic, concern has been raised about the potential effects of
SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B …